Abstract LB-B33: Nonclinical Safety Evaluation of Two Distinct Second Generation Variants of Anti-Ctla4 Monoclonal Antibody, Ipilimumab, in Monkeys
Molecular Cancer Therapeutics(2018)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined